(1)
In-Silico Drug Design And Adme Studies Of Substituted 1, 3, 4-Oxadiazole Analogues As Potent Mycobacterial Dpre1 Enzyme Inhibitors. Journal of Pharmaceutical Negative Results 2023, 2793-2803. https://doi.org/10.47750/pnr.2023.14.S02.329.